Clinical Trial Update: Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating the effect of phosphate binders on FGF-23 levels in chronic kidney disease, with concurrent cal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Calcitriol (calcitriol)
• Phosphate binder (class) (phosphate binder)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Chronic Kidney Disease Stage 3 | Phase 4 | Status: COMPLETED